Latest / Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
INHALE-3 and Diabetes Tech Updates, with Grazia Aleppo, MD
At the 84th American Diabetes Association (ADA) Scientific Sessions, INHALE-3 was among the trials to take center stage.A phase 4 trial comparing the use of inhaled insulin (Afrezza) against standard care, results demonstrated use of inhaled insulin, in addition to insulin degludec, was associated with improved HbA1c in patients with type 1 diabetes, with an improvement of 0.5% or greater observed among 21% of those on inhaled insulin and 5% of those with usual care.At the meeting, study investigator Grazia Aleppo, MD, professor of Medicine and director of the Diabetes Center at Northwestern…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.